These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16767066)

  • 21. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation in end-stage renal disease--what have we learned in 10 years?
    Carrero JJ; Stenvinkel P
    Semin Dial; 2010; 23(5):498-509. PubMed ID: 21039875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular mortality in end-stage renal disease.
    Collins AJ
    Am J Med Sci; 2003 Apr; 325(4):163-7. PubMed ID: 12695721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
    Di Benedetto A; Marcelli D; D'Andrea A; Cice G; D'Isa S; Cappabianca F; Pacchiano G; D'Amato R; Oggero AR; Bonanno D; Pergamo O; Calabrò R
    J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palliative care in the treatment of end-stage renal failure.
    Werb R
    Prim Care; 2011 Jun; 38(2):299-309, ix. PubMed ID: 21628040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease as a late complication of end-stage renal disease in children.
    Groothoff JW; Lilien MR; van de Kar NC; Wolff ED; Davin JC
    Pediatr Nephrol; 2005 Mar; 20(3):374-9. PubMed ID: 15549413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
    Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
    Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and types of cardiovascular disease in patients with end-stage renal disease undergoing renal transplantation.
    Bozbas H; Altin C; Karacaglar E; Kanyilmaz S; Yildirir A; Muderrisoglu H; Haberal M
    Transplant Proc; 2013; 45(10):3478-80. PubMed ID: 24314936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation in end-stage renal disease: sources, consequences, and therapy.
    Stenvinkel P; Alvestrand A
    Semin Dial; 2002; 15(5):329-37. PubMed ID: 12358637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients.
    Fung F; Sherrard DJ; Gillen DL; Wong C; Kestenbaum B; Seliger S; Ball A; Stehman-Breen C
    Am J Kidney Dis; 2002 Aug; 40(2):307-14. PubMed ID: 12148103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of chronic inflammation in cardiovascular mortality of uremic patients.
    Panichi V; Taccola D; Migliori M; Consani C; Giovannini L; Tetta C
    Int J Artif Organs; 2003 Jan; 26(1):12-8. PubMed ID: 12602464
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk in diabetic end-stage renal disease patients.
    Wang AY
    J Diabetes; 2011 Jun; 3(2):119-31. PubMed ID: 21599866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vascular risk factors and renal failure].
    Madore F
    Med Sci (Paris); 2004 Dec; 20(12):1100-3. PubMed ID: 15581463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.